A retrospective study assessing the Chronic Spontaneous Urticaria ares triggered by COVID-19 vaccines in patients with well controlled Chronic Spontaneous Urticaria
Latest Information Update: 12 Apr 2022
At a glance
- Drugs Elasomeran (Primary) ; Tozinameran (Primary)
- Indications COVID 2019 infections
- Focus Adverse reactions
Most Recent Events
- 12 Apr 2022 New trial record
- 28 Feb 2022 Results presented at the 2022 Annual Meeting of the American Academy of Allergy, Asthma and Immunology